Human Embryonic Stem Cells Market Projected to Reach $ 10.7 Billion by 2015
This report examines technology developments, trends, manufacturing, and supply of hESCs
Rockville, MD, August 13, 2010 --(PR.com)-- MarketResearch.com has announced the addition of Industry Experts’s new report “Human Embryonic Stem Cells (hESC) - A Global Market Overview” their collection of Biotechnology market reports. For more information, visit http://www.marketresearch.com/product/display.asp?ProductID=2745408.
Embryonic stem cell (hESC) research has attracted a lot of attention the world over and the controversy surrounding it just does not seem to die down.
Stem cells are unspecialized cells that are capable of differentiating into any other cell type. In addition to being crucial for humans, stem cells also form an important tool in research for finding cures for a host of diseases. Adult, umbilical cord blood and embryos constitute the three sources of stem cells, of which embryonic stem cells have been the subject of major research activities.
Embryonic Stem Cell Technologies analyzed in this study include Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other. The report also analyzes the market for hESC therapeutic areas including Central Nervous System (CNS), Tissue Engineering, Oncology, Cardiology and Other Disease Areas. The worldwide market for hESCs is estimated at US$3.8 billion in 2010. Growing at a robust CAGR of 24.8% during the period 2007-2015, the market is projected to reach US$10.7 billion by 2015.
The report reviews, analyses and projects the hESCs market for global and the regional markets including North America, Europe, Asia-Pacific, and Rest of World. The regional markets further analyzed for 12 independent countries across North America - United States, Canada and Mexico; Europe - United Kingdom, Germany, France, Spain, Sweden and Rest of Europe; Asia-Pacific -India, China, Japan, Australia and Rest of Asia-Pacific.
For more information, visit http://www.marketresearch.com/product/display.asp?ProductID=2745408.
Contact:
Veronica Franco
MarketResearch.com
vfranco"@"marketresearch.com
240.747.3016
###
Embryonic stem cell (hESC) research has attracted a lot of attention the world over and the controversy surrounding it just does not seem to die down.
Stem cells are unspecialized cells that are capable of differentiating into any other cell type. In addition to being crucial for humans, stem cells also form an important tool in research for finding cures for a host of diseases. Adult, umbilical cord blood and embryos constitute the three sources of stem cells, of which embryonic stem cells have been the subject of major research activities.
Embryonic Stem Cell Technologies analyzed in this study include Stem Cell Transplants, Cell Based Genomics, Xenotransplants and Other. The report also analyzes the market for hESC therapeutic areas including Central Nervous System (CNS), Tissue Engineering, Oncology, Cardiology and Other Disease Areas. The worldwide market for hESCs is estimated at US$3.8 billion in 2010. Growing at a robust CAGR of 24.8% during the period 2007-2015, the market is projected to reach US$10.7 billion by 2015.
The report reviews, analyses and projects the hESCs market for global and the regional markets including North America, Europe, Asia-Pacific, and Rest of World. The regional markets further analyzed for 12 independent countries across North America - United States, Canada and Mexico; Europe - United Kingdom, Germany, France, Spain, Sweden and Rest of Europe; Asia-Pacific -India, China, Japan, Australia and Rest of Asia-Pacific.
For more information, visit http://www.marketresearch.com/product/display.asp?ProductID=2745408.
Contact:
Veronica Franco
MarketResearch.com
vfranco"@"marketresearch.com
240.747.3016
###
Contact
MarketResearch.com
Veronica Franco
240.747.3016
www.marketresearch.com/
Veronica Franco
240.747.3016
www.marketresearch.com/
Contact
Categories